Losartan Potassium Tablet
Product Images NDC 68180-307

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68180-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 01

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 01
Chemical structure of losartan potassium, showing its molecular arrangement including a chlorinated pyrimidine ring, biphenyl group, and potassium ion.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 02

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 02
A line graph comparing the percentage of patients with the primary endpoint over study months for Atenolol and Losartan. The graph plots study duration (0 to 66 months) on the x-axis and percentage of patients on the y-axis. It notes an adjusted risk reduction of 13% with a p-value of 0.021 favoring Losartan.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 03

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 03
A line graph comparing the percentage of patients experiencing fatal or non-fatal stroke over study months for Atenolol and Losartan. The graph shows lower stroke rates with Losartan (solid line) versus Atenolol (dotted line), with an adjusted risk reduction of 25% and p-value of 0.001.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 04

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 04
A forest plot comparing Losartan Potassium and Atenolol event rates and hazard ratios in various patient subgroups for primary composite outcomes and stroke (fatal/non-fatal). The chart displays patient numbers, event rates (%), and 95% confidence intervals for hazard ratios, showing which drug is favored across groups such as age, gender, race, isolated systolic hypertension (ISH), diabetes, and cardiovascular disease history.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 05

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 05
A line graph comparing the percentage of patients with an event over 48 months between Losartan and a placebo. The solid line represents Losartan, while the dashed line represents placebo. The graph indicates a risk reduction of 16.1% with Losartan, with a p-value of 0.022.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 06

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 06
Losartan Potassium 25 mg film-coated tablets in a package of 30 tablets. The label shows the product name, strength, and dosage form, with storage instructions at 25°C (77°F) and protection from light. Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and by Lupin Limited, India. The label includes an NDC 68180-210-06 and a barcode.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 07

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 07
Label for Losartan Potassium Tablets USP, 25 mg, oral film-coated tablets. The package contains 30 tablets. Manufactured by Lupin Limited, India, for Lupin Pharmaceuticals, Inc., Baltimore, Maryland. The label includes storage instructions and a barcode.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 08

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 08
Label for Losartan Potassium Tablets USP 50 mg film-coated tablets, containing 30 tablets per package. Manufactured for Lupin Pharmaceuticals, Inc. and by Lupin Limited in India. Includes storage instructions, dosage note, bar code, NDC 68180-211-06, and manufacturer addresses.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 09

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 09
Label for Losartan Potassium Tablets USP 50 mg oral tablets, manufactured by Lupin Pharmaceuticals, Inc. and Lupin Limited. The label states a package size of 30 tablets, prescription only, and includes storage instructions to protect from light and keep the container tightly closed. NDC 68180-211-06 is displayed along with a barcode.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 10

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 10
The label for Losartan Potassium Tablets USP 100 mg shows a film-coated tablet dosage form. The package contains 30 tablets and is manufactured for Lupin Pharmaceuticals, Inc. and by Lupin Limited in India. Storage instructions recommend keeping the container tightly closed and protecting it from light at controlled room temperature. The label includes a barcode and space for lot and expiration information.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 11

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 11
Label for Losartan Potassium Tablets USP 100 mg oral tablets, supplied in a package of 30 tablets. The label includes storage instructions, manufacturer information for Lupin Pharmaceuticals, Inc. and Lupin Limited, and notes the product is Rx only. The label also features the NDC 68180-212-06 and a barcode.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 12

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 12
Label for Losartan Potassium Tablets USP 25 mg by Lupin Pharmaceuticals, Inc. The film-coated oral tablets come in a bottle containing 30 tablets. The label includes storage instructions and manufacturer details for Lupin Pharmaceuticals in the U.S. and Lupin Limited in India.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 13

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 13
Packaging label for Losartan Potassium Tablets USP 25 mg by Lupin Pharmaceuticals, Inc. The label indicates each film-coated tablet contains 25 mg of losartan potassium. It is a prescription-only oral tablet product, with a package size of 30 tablets. Storage instructions and manufacturer details for Lupin Pharmaceuticals and Lupin Limited, India, are also included.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 14

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 14
Losartan Potassium Tablets USP 50 mg film-coated tablets in a carton label. Contains 30 tablets per package. The label shows storage instructions and manufacturer details for Lupin Pharmaceuticals, Inc. and Lupin Limited. The label is primarily white with a blue box highlighting the 50 mg strength and green vertical band on the left.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 15

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 15
Label for Losartan Potassium Tablets USP 50 mg oral tablets by Lupin Pharmaceuticals, Inc. The carton contains 30 film-coated tablets. Storage instructions specify 25°C with allowed excursions; the label notes manufacturer Lupin Limited in Goa, India, and includes the NDC 68180-377-06.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 16

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 16
Label for Losartan Potassium Tablets USP 100 mg by Lupin Pharmaceuticals, Inc. The label indicates each film-coated tablet contains 100 mg of losartan potassium, with a package size of 30 tablets. Storage instructions and manufacturer details for Lupin Pharmaceuticals in Maryland and Lupin Limited in India are also shown.*
FDA Label Image

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 17

B20b3678 Bd1a 4ca6 9f79 B4a27aa003bd 17
Label for Losartan Potassium Tablets USP 100 mg, oral tablet dosage form, manufactured by Lupin Pharmaceuticals, Inc. The label indicates packaging of 30 film-coated tablets. It includes storage instructions, manufacturer details, and a barcode, clearly stating 'Rx only.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.